BackRocket Pharmaceuticals Overview
Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Target Price

Analysts' 12-month price predictions for RCKT.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.86

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-01-08Morgan Stanley$574.8% upsideOpen
2025-10-03Leerink Partners$7144.8% upsideOpen
2025-05-28Goldman SachsRichard Law$230.1% downsideOpen
2025-05-28JefferiesAndrew Tsai$2.512.6% downsideOpen
2024-12-30WedbushYun Zhong$321018.9% upsideOpen
2024-11-11Canaccord GenuityWhitney Ijem$391263.6% upsideOpen
2024-09-18Canaccord GenuityWhitney Ijem$381228.7% upsideOpen
2024-09-17Morgan StanleyMichael E Ulz$451473.4% upsideOpen
2024-04-02Goldman SachsRichard Law$391263.6% upsideOpen
2022-10-03Raymond James$341088.8% upsideOpen
2022-08-09Raymond James$24739.2% upsideOpen
2021-08-12UBSEsther Rajavelu$692312.6% upsideOpen